Recently, with the official release of Shanghai's sixth "New and Superior Medical Devices & Pharmaceuticals" catalog, Pongce Medical's innovative journey has once again received strong government endorsement. This follows the inclusion of its initial products in 2024, marking another milestone as Songjiang's cutting-edge medical devices and pharmaceuticals secure city-level authoritative recognition once again.

　　This selection signifies that the HAIRO hair transplant surgical robot will significantly enhance its competitiveness in hospital procurement bidding processes, removing key policy barriers that have previously hindered the product's rapid large-scale market adoption and boosting its commercial value. At the same time, it will strongly support Songjiang in accelerating the development of its integrated industry ecosystem—spanning "R&D, clinical application, manufacturing, and implementation"—and inject powerful momentum into Shanghai's efforts to establish itself as a global hub for the biopharmaceutical industry.

　　Meanwhile, Pangce Medical was successfully selected for the "2025 China Healthcare Growth List—Top 100 Innovators in Smart Healthcare," released by Health Kaige and the Health Kaige Institute. This year's ranking system has been comprehensively upgraded, expanding from three key dimensions to eight, with hundreds of detailed metrics incorporated. The evaluation framework deeply integrates strategic models such as the Balanced Scorecard (BSC) and the Ansoff Matrix, creating a "gold standard" for assessing growth in the healthcare sector.

　　Being selected for this list is a triple endorsement of Pongce Medical’s technological innovation capabilities, business model, and overall growth potential. The results of the “penetrative analysis,” based on hundreds of key indicators, firmly demonstrate Pongce Medical’s leading position in the smart healthcare sector as well as its ability to achieve sustainable development, significantly boosting both market confidence and the trust of its partners in the company’s future prospects.

　　As Pongce makes its mark on two prestigious lists, the company has another milestone to celebrate: Founder and Chairman Mr. Zhang Zhaodong was recently named to Cyzone's "35 Under 35 Entrepreneurial Trailblazers of 2025." This exclusive list is meticulously curated by a panel of 12 leading investment firm experts, recognizing young entrepreneurs who not only demonstrate exceptional innovation but also deliver significant social value. Over the past 14 years, only 306 entrepreneurs have earned this distinguished honor. Mr. Zhang's inclusion on the list not only underscores his personal entrepreneurial achievements but also serves as a powerful endorsement of Pongce's groundbreaking innovations in the medical robotics field.

　　From clinical needs to technological implementation, from industry rankings to policy frameworks, Pangce and HAIRO are reshaping the hair restoration industry landscape with Chinese ingenuity, creating greater value for both doctors and patients. Looking ahead, as technology continues to evolve and its clinical applications deepen, the Pangce HAIRO hair transplant surgical robot aspires to become a global "Chinese calling card" in the field of hair care and treatment.